Literature DB >> 10825032

Antibiotic use in the elderly: issues and nonissues.

J D McCue1.   

Abstract

Despite the well-recognized increase in mortality and morbidity due to infections in the elderly, antibiotics may, in most cases, be used in a manner similar to that in younger patients. The decreased lean body weight and reduced renal function typical of elderly patients, however, require consideration of reduced doses and longer dosing intervals, especially for renally excreted antibiotics. Length of therapy should be conservative because underlying anatomic or functional predispositions to infections tend to complicate treatment. Oral antibiotics are equally well absorbed in the elderly and younger patients and may be used for the same indications as for younger patients. A notable, important difference in the choice of antibiotics for serious infections in older versus younger patients is that empirical therapy should be broader in spectrum for elderly patients, and especially for elderly long-term residents, since the variety of infecting bacteria tends to be greater and polymicrobial infections tend to be common.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10825032     DOI: 10.1086/515210

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

1.  Antimicrobial prescribing in hospitalized adults stratified by age: data from the ESAC point-prevalence surveys.

Authors:  Peter Zarb; Brice Amadeo; Arno Muller; Nico Drapier; Vanessa Vankerckhoven; Peter Davey; Herman Goossens
Journal:  Drugs Aging       Date:  2012-01-01       Impact factor: 3.923

Review 2.  New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

Authors:  Anna Maria Ferrara; Anna Maria Fietta
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

3.  Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.

Authors:  Kendra N Iskander; Marcin F Osuchowski; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa; David Stepien; Catherine Valentine; Daniel G Remick
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.